Screener
Xenon Pharmaceuticals XENE Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $119.53M-11.7% | $545.87M+368% | $199.16M+39.6% | $104.51M+19.3% | $135.38M-1.0% | ||
| $811.16M+130% | $548.88M+26.8% | $349.72M-27.8% | $357.75M-36.8% | $352.16M-39.8% | ||
| $945.87M+89.1% | $1.11B+95.7% | $560.65M-11.7% | $480.14M-27.2% | $500.25M-31.3% | ||
| $7.77M-15.5% | $8.29M-14.5% | $8.72M-15.1% | $8.89M-12.5% | $9.21M-9.2% | ||
| $1.3B+92.2% | $1.39B+86.6% | $633.16M-20.7% | $607.84M-27.3% | $674.28M-23.7% | ||
| $43.67M+38.3% | $38.25M+24.8% | $40.26M+17.6% | $36.84M+30.1% | $31.59M+5.5% | ||
| $45.01M+36.2% | $39.82M+24.3% | $41.79M+17.4% | $38.34M+29.1% | $33.05M+5.6% | ||
| $53.38M+32.4% | $48.99M+24.6% | $51.4M+18.9% | $48.33M+26.9% | $40.3M+0.8% | ||
| $2.43B+65.2% | $2.42B+65.8% | $1.6B+9.7% | $1.48B+2.3% | $1.47B+2.0% | ||
| -$1.46B-39.0% | -$1.35B-39.7% | -$1.25B-38.5% | -$1.14B-36.7% | -$1.05B-36.1% | ||
| $1.24B+96.0% | $1.34B+90.0% | $581.76M-22.9% | $559.51M-29.9% | $633.98M-24.9% | ||
| $1.3B+92.2% | $1.39B+86.6% | $633.16M-20.7% | $607.84M-27.3% | $674.28M-23.7% |
FAQ
- What are Xenon Pharmaceuticals's total assets?
- Xenon Pharmaceuticals (XENE) holds $1.3B in total assets, up 92.2% year over year.
- How much debt does Xenon Pharmaceuticals have?
- Xenon Pharmaceuticals carries $6.4M in total debt against $1.2B of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Xenon Pharmaceuticals have?
- Xenon Pharmaceuticals holds $119.5M in cash and equivalents.
- Can Xenon Pharmaceuticals cover its short-term obligations?
- Its current ratio is 21.02 — current assets exceed current liabilities.
- Where does Xenon Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Xenon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.